Trials / Completed
CompletedNCT01055977
Statin Therapy Results in the Real World Practice in the Czech Republic
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 3,253 (estimated)
- Sponsor
- AstraZeneca · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Statins are the first choice treatment of dyslipidemia, a major contributor to cardiovascular diseases. Statins also have enough evidence to demonstrate decrease of morbidity and mortality from cardiovascular diseases. Even though statin therapy is effective treatment of dyslipidaemia not all patients reach the goal levels. The aim of the study is to estimate proportion of patients who achieved the therapeutic goal (LDL-C. total cholesterol, HDL-C and triglycerides levels) after at least one year of a statin therapy.
Conditions
Timeline
- Start date
- 2010-02-01
- Primary completion
- 2010-06-01
- Completion
- 2010-06-01
- First posted
- 2010-01-26
- Last updated
- 2011-08-30
Locations
95 sites across 1 country: Czechia
Source: ClinicalTrials.gov record NCT01055977. Inclusion in this directory is not an endorsement.